2509 9h20 kessler usoinseguro

Information about 2509 9h20 kessler usoinseguro

Published on May 2, 2008

Author: Jolene

Source: authorstream.com

Content

Unsafe Use of Drugs: Death and Harm:  Unsafe Use of Drugs: Death and Harm Presented by John M. Kessler, Pharm. D., B.C.P.S. Assistant Director of Pharmacy Duke University Medical Center Safe Medication Use:  Safe Medication Use What does it mean to be “unsafe”? Accidents, slips, mistakes? Failure to act? Unforeseen adverse reactions? Unforeseen adverse interactions? Poor judgment? Safe Medication Use:  Safe Medication Use Which are medication errors? 2.2 kg = 1 pound Aspirin EC 325mg now heart attack Insulin 20 U SQ now and repeat daily LDL-chol of 180 mg% (untreated) after stroke Salmeterol 2 puffs now for breathing Safe Medication Use:  Safe Medication Use Which are medication errors? Treating an infant’s fever with aspirin Hypotension after vancomycin inj. Prescribing warfarin and aspirin together Dispensing prescriptions for prenatal vitamins and captopril Safe Medication Use:  Safe Medication Use Safety is CREATED when there is good planning AND good execution Safe Medication Use:  Safe Medication Use Harm is CREATED when there is an active error (mistake) AND injury to a patient (or lack of the desired effect) Safe Medication Use:  Safe Medication Use Harm is REDUCED when an active error (mistake) AND injury to a patient are detected at the earliest possible time Safe Medication Use:  Safe Medication Use REDUCING HARM is a PRIMARY GOAL of our Medication Safety Program Safe medication use: reducing harm:  Safe medication use: reducing harm Making Health Care Safer: A critical analysis of patient safety practices Agency for Healthcare Research and Quality (AHRQ) July 18, 2001 www.ahqr.gov Safe medication use: reducing harm:  Safe medication use: reducing harm Very High Evidence of Effectiveness Appropriate pre-operative antibiotics Patient self-monitoring of warfarin Perioperative beta-blocker use in non-cardiac surgery Safe medication use: reducing harm:  Safe medication use: reducing harm High Evidence of Effectiveness Monitoring high alert drugs (e.g. KCl, heparin, antibiotics, morphine) Decreasing drug-induced delirium Improving pain control with non-drug therapies Safe medication use: reducing harm:  Safe medication use: reducing harm High Evidence of Effectiveness Information sharing between outpatient and inpatient pharmacies Supplemental O2 decreases surgical site infections Gut decontamination reduces rate of ventilator-associate pneumonias Safe medication use: reducing harm:  Safe medication use: reducing harm Moderate Evidence of Effectiveness Computerized doctor order entry Clinical pharmacist consultations Perioperative glucose control Anticoagulation services/clinics Pneumococcal/influenza vaccines Safe medication use: reducing harm:  Safe medication use: reducing harm Moderate Evidence of Effectiveness Prevention of GI stress ulcers/bleed Multidisciplinary pain consult team Antibiotic guidelines resistance Protocols for high alert drugs (e.g. heparin) Safe medication use: reducing harm:  Safe medication use: reducing harm Moderate Evidence of Effectiveness Computerized doctor order entry Clinical pharmacist consultations Perioperative glucose control Anticoagulation services/clinics Pneumococcal/influenza vaccines Safe medication use: reducing harm:  Safe medication use: reducing harm Lower Evidence of Effectiveness Heparin flush central line infection Automated drug dispensing devices Bar coding for patient identification Unit dose drug distribution Sucralfate vent. pneumonia Dangerous Medications:  Dangerous Medications Concentrated drugs and large volume containers can kill Potassium (KCl, KPO4, K- acetate) Epinephrine 1 ml and 30 ml vials Bulk chemotherapy vials Vasopressor - mcg/min, mcg/kg or mcg/kg/min? Unsafe Medication Practices:  Unsafe Medication Practices “Line switches” can be deadly high risk - drugs administered by continuous infusion IV pumps must trace lines from IV to patient use “change of shift” line checks environmental control - (e.g. good lighting, minimize distractions) “Line switches” can be deadly:  “Line switches” can be deadly Intensively monitor these IV’s- difficult to detect adverse events Insulin (before and after infusion) Heparin (before and after infusion) Electrolytes (K, Mg, Ca) Thrombolytics (tPA) “Line switches” can be deadly:  “Line switches” can be deadly Intensively monitor these IV’s- easier to detect adverse events Morphine/opiate analgesics Dopamine, norepi, epi, isoproterenol Midazolam Safe Medication Use:  Safe Medication Use Monitoring for safety and efficacy Sedation (fentanyl and midazolam) Oxygen saturation Pain assessment and vital signs Level of consciousness Recovery to baseline after sedation Safe Medication Use:  Safe Medication Use Monitoring for safety and efficacy Antibiotic therapy Duration of use (minimize days of tx) Bacterial sensitivities (microbiology) Renal and liver function changes Drug levels (for selected drugs) Missed doses Safe Medication Use:  Safe Medication Use Monitoring for safety and efficacy Heparin Rate of administration Dose or rate change (high risk action) Write target aPTT or ACT Standardize concentration in IV bag. Safe Medication Use:  Safe Medication Use Monitoring for safety and efficacy Insulin infusions Standardize concentration in IV bag Monitor glucose Sliding scales can be dangerous Standardized order sets Dose adjustment plan (e.g. meals) Safe Medication Use:  Safe Medication Use Rules for safety and efficacy Verbal orders Not allowed for chemotherapy, investigational drugs, insulin, t’lytics Culture that allows and rules that require “checks” for accuracy Write orders immediately Safe Medication Use:  Safe Medication Use Rules for safety and efficacy Unsafe abbreviations for drug names (MS04, 5 FU, rPA, VCR) Standardized concentrations Pre-printed medication orders Standardized administration times Institute for Safe Medication Practices:  Institute for Safe Medication Practices ISMP (www.ismp.org) Michael Cohen, FASHP Awareness of cause of errors Self-assessment survey Non-punitive culture for reporting Use “forcing functions” to do right Institute for Safe Medication Practices:  Institute for Safe Medication Practices 2 Major Goals after the I.O.M. report Eliminate handwritten scripts within 3 years White paper on errors and technology (see website) Benchmarking survey of hospital practices Self-assessment with comparative reports to be available (1,435 usable responses) 194 questions 20 core distinguishing characteristics of a safe med system 5 degrees of implementation (not discussed……fully implemented) ISMP’s 10 elements for self assessment:  ISMP’s 10 elements for self assessment Patient information Drug information Communication of drug/patient information Package labeling, packaging, nomenclature Drug standardization, storage, distribution Delivery device acquisition, use, monitoring Environmental Staff education/competency Patient education Quality improvement and risk management processes Education and Credentialling:  Education and Credentialling In the United States, my automobile mechanic receives more training on his diagnostic machines, than most practitioners receive about new drugs! Education and Credentialling:  Education and Credentialling At Duke, all new Formulary items include a drug data sheet that lists unbiased comparative information and key criteria for monitoring safe and effective drug use. All new drugs have an educational plan when they are approved. Education and Credentialling:  Education and Credentialling 3 Levels of Education I - general announcements/news II - targeted group education III - individual credentialling (dofetilide, thalidomide, sedation, chemotherapy, epoprostenol) Summary:  Summary Creating safety means…. Identifying high alert medications Identifying high risk practices Developing effective drug monitoring Developing “safe” reporting systems Planning, monitoring, improving Perguntas e Debates:  Perguntas e Debates Obrigando a todos pela atenção e estou pronto para perguntas e debates

Related presentations


Other presentations created by Jolene

Smart Dust and Micro Robots
07. 01. 2008
0 views

Smart Dust and Micro Robots

whats driving emerging markets
27. 09. 2007
0 views

whats driving emerging markets

Barrie Peter Pan Text Only
12. 10. 2007
0 views

Barrie Peter Pan Text Only

rutherford winterjohnson
13. 10. 2007
0 views

rutherford winterjohnson

chap3 2
16. 10. 2007
0 views

chap3 2

IntroDNACloningDNARep
16. 10. 2007
0 views

IntroDNACloningDNARep

MOAC204
17. 10. 2007
0 views

MOAC204

nile hydrology
23. 10. 2007
0 views

nile hydrology

12 HACCPJuiceSeafood French
24. 10. 2007
0 views

12 HACCPJuiceSeafood French

politiques Sant Boi Pere Dorca
24. 10. 2007
0 views

politiques Sant Boi Pere Dorca

thomson
15. 10. 2007
0 views

thomson

climate change and poverty
29. 11. 2007
0 views

climate change and poverty

botnet underground economics
04. 12. 2007
0 views

botnet underground economics

Macroevolution
12. 10. 2007
0 views

Macroevolution

Roman Religion powerpoint
29. 10. 2007
0 views

Roman Religion powerpoint

2268Atakan
31. 10. 2007
0 views

2268Atakan

Banned Books
31. 10. 2007
0 views

Banned Books

Bob
01. 11. 2007
0 views

Bob

Week 3 DW Design Kimball
07. 11. 2007
0 views

Week 3 DW Design Kimball

STILLEHAVSKRIGEN3
13. 11. 2007
0 views

STILLEHAVSKRIGEN3

enhancing osh standards
14. 11. 2007
0 views

enhancing osh standards

ELISA 2004
12. 10. 2007
0 views

ELISA 2004

Climate McBean f
21. 10. 2007
0 views

Climate McBean f

PP 08 Conditioning
16. 11. 2007
0 views

PP 08 Conditioning

Ontologies in Bioinformatics
20. 11. 2007
0 views

Ontologies in Bioinformatics

laminas centroamÃrica
22. 10. 2007
0 views

laminas centroamÃrica

1World War II
23. 12. 2007
0 views

1World War II

NOAA Fisheries NMFS
28. 12. 2007
0 views

NOAA Fisheries NMFS

ClassDay4
31. 12. 2007
0 views

ClassDay4

ENGR310 1 07
03. 01. 2008
0 views

ENGR310 1 07

PAN Villarreal
22. 10. 2007
0 views

PAN Villarreal

gpr
05. 01. 2008
0 views

gpr

hansen
29. 10. 2007
0 views

hansen

3 El Hattab Ahamed
25. 10. 2007
0 views

3 El Hattab Ahamed

marrocos2
24. 10. 2007
0 views

marrocos2

NWS Partnering
05. 10. 2007
0 views

NWS Partnering

Lyster
16. 10. 2007
0 views

Lyster

webcast1
29. 10. 2007
0 views

webcast1

Chicago
15. 10. 2007
0 views

Chicago

Faridah Noor Indian Dance New
23. 11. 2007
0 views

Faridah Noor Indian Dance New

xmm UG 051606
28. 11. 2007
0 views

xmm UG 051606

ISOM7
15. 10. 2007
0 views

ISOM7

Thermocouple
16. 02. 2008
0 views

Thermocouple

Gubler
21. 10. 2007
0 views

Gubler

test5
30. 10. 2007
0 views

test5

pit 2
26. 02. 2008
0 views

pit 2

m6 Eyler
28. 02. 2008
0 views

m6 Eyler

PSCM
07. 03. 2008
0 views

PSCM

pfl powerpoint may06
10. 03. 2008
0 views

pfl powerpoint may06

Prasa2001
13. 03. 2008
0 views

Prasa2001

PresentationANALYSTE SSNI2006
24. 10. 2007
0 views

PresentationANALYSTE SSNI2006

Perine I2 22april04
16. 03. 2008
0 views

Perine I2 22april04

Panel B Igor Hansen
20. 03. 2008
0 views

Panel B Igor Hansen

kapil kaul
25. 03. 2008
0 views

kapil kaul

part1 intro
07. 10. 2007
0 views

part1 intro

ans1 ffa program
03. 04. 2008
0 views

ans1 ffa program

Jonah
07. 04. 2008
0 views

Jonah

051208 Osawa
09. 10. 2007
0 views

051208 Osawa

3arq
18. 10. 2007
0 views

3arq

Bourgeat Siam
06. 12. 2007
0 views

Bourgeat Siam

allen
08. 04. 2008
0 views

allen

Fry 2005
10. 04. 2008
0 views

Fry 2005

ValueofNonpartisan
14. 04. 2008
0 views

ValueofNonpartisan

lovelock12
16. 04. 2008
0 views

lovelock12

Pumpkin SmallSat 2006
17. 04. 2008
0 views

Pumpkin SmallSat 2006

CSAM DOJ Briefing Day2
22. 04. 2008
0 views

CSAM DOJ Briefing Day2

SOUTHEAST pp
03. 01. 2008
0 views

SOUTHEAST pp

Arbetslagsplan 04 05
02. 11. 2007
0 views

Arbetslagsplan 04 05

dentist
06. 05. 2008
0 views

dentist

critical care slides
07. 05. 2008
0 views

critical care slides

origins
08. 05. 2008
0 views

origins

mas info
08. 05. 2008
0 views

mas info

18 4
22. 10. 2007
0 views

18 4

Vulvodynia
01. 05. 2008
0 views

Vulvodynia

014 Robot Control Architectures
02. 05. 2008
0 views

014 Robot Control Architectures

3678s1 03 schechter
02. 05. 2008
0 views

3678s1 03 schechter

Dana Guerrieri
02. 05. 2008
0 views

Dana Guerrieri

Anestezja
02. 05. 2008
0 views

Anestezja

lezersp1
15. 10. 2007
0 views

lezersp1

20050928 Yasuyuki Fuchita
09. 10. 2007
0 views

20050928 Yasuyuki Fuchita

S Pathi
16. 10. 2007
0 views

S Pathi

Thompson Adjusted
30. 04. 2008
0 views

Thompson Adjusted

Poretti dscut Gdor CW8
15. 11. 2007
0 views

Poretti dscut Gdor CW8

2002 04 maintenance
19. 11. 2007
0 views

2002 04 maintenance

N1 Richard News from ELAN Paris
29. 09. 2007
0 views

N1 Richard News from ELAN Paris

cal20050303
09. 10. 2007
0 views

cal20050303

2007 FL GHC ICC Tezak Kilcollins
05. 10. 2007
0 views

2007 FL GHC ICC Tezak Kilcollins

TUD About the institution
18. 03. 2008
0 views

TUD About the institution

iPOP2007 OIF Berthold
09. 10. 2007
0 views

iPOP2007 OIF Berthold

patricia arsene
15. 10. 2007
0 views

patricia arsene

IHS 2003
27. 03. 2008
0 views

IHS 2003

MOTIVATE 1 slides
29. 10. 2007
0 views

MOTIVATE 1 slides

Alia2003
05. 10. 2007
0 views

Alia2003

RE SUNUM ppt2
23. 11. 2007
0 views

RE SUNUM ppt2

grid2000 welcome
17. 10. 2007
0 views

grid2000 welcome

Larry
07. 01. 2008
0 views

Larry

Abel
25. 10. 2007
0 views

Abel

Weitz Tracy 1 24 07
03. 01. 2008
0 views

Weitz Tracy 1 24 07

del rel
07. 11. 2007
0 views

del rel

ilc analyse
23. 10. 2007
0 views

ilc analyse

CAS 07 MDHS
02. 05. 2008
0 views

CAS 07 MDHS